CNS-manifestation of aspergillosis in an extremely low-birth-weight infant

European Journal of Pediatrics

Volumn 165, Issue 7, 2006, Pages 476-480

  Fuchs, Hans ^a   Von Baum, Heike ^a   Meth, Martina ^a   Wellinghausen, Nele ^a   Lindner, Wolfgang ^a   Hummler, Helmut ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Aspergillosis; Infant; Intraventricular haemorrhage; Newborn; Periventricular leukomalacia; Very low birth weight infant

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ANTIMICROBIAL THERAPY; ARTICLE; ASCITES; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN BIOPSY; BRAIN HEMORRHAGE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EXTREMELY LOW BIRTH WEIGHT; FATALITY; FUNGUS ISOLATION; GESTATIONAL AGE; HUMAN; INFANT; LEUKOMALACIA; LUNG ASPIRATION; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RARE DISEASE; SYSTEMIC DISEASE; ULTRASOUND;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; TWINS, MONOZYGOTIC;

EID: 33744472234     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0111-6     Document Type: Article

References (32)

1. Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, Durocher A (2005) Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 11:427-429
2. Ben Rejeb A, Boubaker S, Turki I, Massaoudi L, Chibani M, Khouja H (1993) Placental aspergillosis: myth or reality? Apropos of a case with fetal death in utero. J Gynecol Obstet Biol Reprod 22:85-89
3. Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Hehlmann R (2004) Current molecular diagnostic approaches to systemic infections with aspergillus species in patients with hematological malignancies. Leukemia Lymphoma 45:463-468
4. Chiang AK, Chan GC, Ma SK, Ng YK, Ha SY, Lau YL (2000) Disseminated fungal infection associated with myeloperoxidase deficiency in a premature neonate. Pediatr Infect Dis J 19:1027-1029
5. Galimberti R, Kowalczuk A, Hidalgo Parra I, Gonzalez Ramos M, Flores V (1998) Cutaneous aspergillosis: a report of six cases. Br J Dermatol 139:522-526
6. Groll AH, Jaeger G, Allendorf A, Herrmann G, Schloesser R, von Loewenich V (1998) Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis 27:437-452
7. Groll AH, Giri N, Petraitis V, Petraitiene R, Candelario M, Bacher JS, Piscitelli SC, Walsh TJ (2000) Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 182:274-282
8. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Invasive fungal infections group of the European organisation for research and treatment of cancer and the global aspergillus study group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415
9. Herron MD, Vanderhooft SL, Byington C, King JD (2003) Aspergillosis in a 24-week newborn: a case report. J Perinatol 23:256-259
10. Kontoyiannis DP, Mantadakis E, Samonis G (2003) Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect 53:243-258
11. Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358-366
12. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Eldere J, Verbist L, Boogaerts M (1999) Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 37:3223-3228
13. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 186:1297-1306
14. Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Vogel M, Versmold H (2000) Fatal aspergillosis with brain abscesses in a neonate with DiGeorge syndrome. Pediatr Infect Dis J 19:1214-1216
15. Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM (1996) Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 17:441-443
16. Muldrew KM, Maples HD, Stowe CD, Jacobs RF (2005) Intravenous voriconazole therapy in a preterm infant. Pharmacotherapy 25:893-898
17. Muller FM, Trusen A, Weig M (2002) Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr 161:563-574
18. Phillips P, Shafran S, Garber G, Rotstein C, Smaill F, Fong I, Salit I, Miller M, Williams K, Conly JM, Singer J, Ioannou S (1997) Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Eur J Clin Microbiol Infect Dis 16:337-345
19. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957-5962
20. Popova NI (1976) Intrauterine destruction of the brain by molds. Ark Patol 38:48-52
21. Richardson V, Ortiz D, Newton OA, Nandi E (2001) Disseminated and cutaneous aspergillosis in a premature infant: a fatal nosocomial infection. Pediatr Dermatol 18:366-367
22. Schwartz DA, Jacquette M, Chawla HS (1988) Disseminated neonatal aspergillosis: report of a fatal case and analysis of risk factors. Pediatr Infect Dis J 7:349-353
23. Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, Schuler U, Lutsar I, Troke P, Thiel E (2005) Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 106:2641-2645
24. Siemann M, Koch-Dorfler M, Gaude M (1998) False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 41:373-377
25. Singer S, Singer D, Ruchel R, Mergeryan H, Schmidt U, Harms K (1998) Outbreak of systemic aspergillosis in a neonatal intensive care unit. Mycoses 41:223-227
26. Steinbach WJ (2005) Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J 24:358-364
27. Strunk T, Temming P, Gembruch U, Reiss I, Bucsky P, Schultz C (2004) Differential maturation of the innate immune response in human fetuses. Pediatr Res 56:219-226
28. Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46:171-179
29. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ (1998) Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 26:1383-1396
30. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21:240-248
31. Woodruff CA, Hebert AA (2002) Neonatal primary cutaneous aspergillosis: case report and review of the literature. Pediatr Dermatol 19:439-444
32. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD (2005) Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis 52:295-298